COMPARATIVE STUDIES ON ACTIVITIES OF ANTIMICROBIAL AGENTS AGAINST CAUSATIVE ORGANISMS ISOLATED FROM PATIENTS WITH URINARY TRACT INFECTIONS (1996)
-
- KUMAMOTO YOSHIAKI
- Department of Urology, Sapporo Medical University, School of Medicine
-
- TSUKAMOTO TAIJI
- Department of Urology, Sapporo Medical University, School of Medicine
-
- HIROSE TAKAOKI
- Department of Urology, Sapporo Medical University, School of Medicine
-
- YOKOO AKIFUMI
- Department of Urology, Sapporo Medical University, School of Medicine
-
- SHIGETA SHIRO
- Department of Bacteriology, Fukushima Medical College
-
- TAKAHASHI TOSHIMITSU
- Department of Bacteriology, Fukushima Medical College
-
- SHIRAIWA YASUO
- Department of Urology, Fukushima Medical College
-
- OGIWARA MASAHIKO
- Department of Urology, Fukushima Medical College
-
- YOSHIDA HIROSHI
- Department of Clinical Laboratory Medicine, Fukushima Medical College
-
- IMAFUKU YUUJI
- Department of Clinical Laboratory Medicine, Fukushima Medical College
-
- MURAI MASARU
- Department of Urology, School of Medicine, Keio University
-
- WATANABE KIYOAKI
- Central Clinical Laboratories, School of Medicine, Keio University
-
- UCHIDA HIROSHI
- Central Clinical Laboratories, School of Medicine, Keio University
-
- KOBAYASHI YOSHIO
- Central Clinical Laboratories, School of Medicine, Keio University
-
- MATSUDA SEIJI
- Department of Gynecology, Koto Hospital
-
- FUJIME MAKOTO
- Department of Urology, Juntendo University, School of Medicine
-
- FUJITA KAZUHIKO
- Department of Urology, Juntendo University, School of Medicine
-
- IGARI JUN
- Department of Clinical Pathology, Juntendo University, School of Medicine
-
- OGURI TOYOKO
- Department of Clinical Laboratories, Juntendo University
-
- YAMAGUCHI KEIZO
- Department of Microbiology, School of Medicine, Toho University
-
- MATSUMOTO TETSUYA
- Department of Microbiology, School of Medicine, Toho University
-
- KASHITANI FUSAKO
- Department of Microbiology, School of Medicine, Toho University
-
- KAKU MITSUO
- Department of Microbiology, St. Marianna University School of Medicine
-
- OOE HIROSHI
- Department of Urology, Kyoto Second Red Cross Hospital
-
- MAEKAWA MIKIO
- Department of Urology, Kyoto Second Red Cross Hospital
-
- NISHIKAWA MINEKO
- Department of Urology, Kyoto Second Red Cross Hospital
-
- YONEZU SEIBUN
- The First Department of Internal Medicine, Kansai Medical University
-
- YAMANAKA YOSHITAKA
- The First Department of Internal Medicine, Kansai Medical University
-
- OKA TOSHITSUGU
- Department of Urology, Osaka National Hospital
-
- TAKANO YUUJI
- Department of Urology, Osaka National Hospital
-
- MIYAGAWA YASUSHI
- Department of Urology, Osaka National Hospital
-
- TANAKA MICHIO
- Clinical Laboratories, Osaka National Hospital
-
- HIRAGATA YOUICHI
- Department Laboratory, School of Medicine, Nagasaki University
-
- YOSHIDA RYOUJI
- Department Laboratory, School of Medicine, Nagasaki University
-
- MOCHIDA CHIKAKO
- Department Laboratory, School of Medicine, Nagasaki University
Bibliographic Information
- Other Title
-
- 尿路感染症分離菌に対する経口並びに注射用抗菌薬の抗菌力比較 (第18報1996年)
- I. SUSCEPTIBILITY DISTRIBUTION
- その1.感受性について
Abstract
The frequencies of isolation and susceptibilities to antimicrobial agents were investigated on 680 bacterial strains isolated from patients with urinary tract infections (UTIs) in 10 hospitals during the period of June 1996 to May 1997. Of the above bacterial isolates, Gram-positive bacteria accounted for 30.4% and a majority of them were Enterococcus faecalis. Gram-negative bacteria accounted for 69.6% and most of them were Escherichia coli.<BR>Susceptibilities of several isolated bacteria to antimicrobial agents were as followed;<BR>1.Enterococcus faecalis<BR>Ampicillin (ABPC) showed the highest activity against E. faecalis isolated from patients with UTIs.Its MIC90 was 1 μg/ml. Imipenem (IPM) and vancomycin (VCM) were also active with the MIC90s of 2,μg/ml. The others had low activities with the MIC90s of 16 μg/ml or above.<BR>2.Staphylococcus aureus including MRSA<BR>Arbekacin (ABK) and VCM showed the highest activities against both S. aureus and MRSA isolated from patients with UTIs. The MIC90s of them were 1 or 2 μg/ml. The others except minocycline (MINO) had low activities with the MIC90s of 32,μg/ml or above.<BR>3.Staphylococcus epidermidis<BR>ABK and VCM showed the strongest activities against S. epidermidis isolated from patients with UTIs. The MICs for all strains were equal to or lower than 2 μg/ml. Cefazolin (CEZ), cefotiam (CTM) and cefozopran (CZOP) were also active with the MIC90s of 4 μg/ml. Compared with antimicrobial activities of cephems in 1995, the MIC90s of them had changed into a better state. They ranged from 4 μg/ml to 16 μg/ml in 1996.<BR>4.Streptococcus agalactiae<BR>All drugs except MINO were active against S. agalactiae. ABPC, CZOP, IPM, and clarithromycin (CAM) showed the highest activities. The MICs for all strains were equal to or lower than 0.125 μg/ml. Tosufloxacin (TFLX) and VCM were also active with the MIC90s of 0.5 μg/ml.<BR>5.Citrobacter freundii<BR>Gentamicin (GM) showed the highest activity against C. freundii isolated from patients with UTIs. Its MIC90 was 0.5,μg/ml. IPM and amikacin (AMK) were also active with the MIC90s of 1μg/ml and 2μg/ml, respectively. Cefpirome (CPR) and CZOP were also active with the MIC90s of 8 gg/ml. The MIC90s of the others were 16 μg/ml or above.<BR>6.Enterobacter cloacae<BR>IPM showed the highest activity against E. cloacae. The MICs for all strains were equal to or lower than 0.5μg/ml. The MIC90s of ciprofloxacin (CPFX) and TFLX were 1μg/ml, the MIC90 of AMK was 2 μg/ml, the MIC90s of CZOP, GM and ofloxacin (OFLX) were 4μg/ml. The MIC50s of cephems except CEZ, cefmetazole (CMZ) and cefaclor (CCL) had changed into a better state in 1996, compared with those in 1995.<BR>7.Escherichia coli<BR>All drugs except penicillins and MINO were active against E. coli. Particularly CPR, CZOP and IPM showed the highest activities against E. coli. The MIC90s of them were 0.125μg/ml or below. Among E. coli strains, those with low susceptibilities to cephems except CEZ, cefoperazone (CPZ), latamoxef (LMOX) and CCL have increased in 1996, compared with those in 1995.<BR>8.Klebsiella pneumoniae<BR>K. pneumoniae was susceptible to all drugs except penicillins, with the MIC90s of 2 μg/ml or below. CPR had the strongest activity, the MICs for all strains were equal to or lower than 0.25μg/ml. Flomoxef (FMOX), cefixime (CFIX), CZOP and carumonam (CRMN) were also active with the MIC90s of 0.125 μg/ml or below.<BR>9.Pseudomonas aeruginosa<BR>All drugs except quinolones were not so active against P.aeruginosa with the MIC90s were 32μg/ml or above.
Journal
-
- The Japanese Journal of Antibiotics
-
The Japanese Journal of Antibiotics 51 (2), 69-111, 1998
Japan Antibiotics Research Association